ReviewFrontiers in oncology2018
Machine Learning and Radiogenomics: Lessons Learned and Future Directions.
Review in Frontiers in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Enabling pregnant women and their physicians to make informed medication decisions using artificial intelligence.Journal of pharmacokinetics and pharmacodynamics · 2020Pooled it
- A genome-wide association study on radiation induced fibrosis in breast cancer patients.Clinical and translational radiation oncology · 2026Article
- Review
- Revolutionizing precision oncology: the role of artificial intelligence in personalized pediatric cancer care.Frontiers in medicine · 2025Review
- The Convergence of Radiology and Genomics: Advancing Breast Cancer Diagnosis with Radiogenomics.Cancers · 2024Review
- A primer on the use of machine learning to distil knowledge from data in biological psychiatry.Molecular psychiatry · 2024Review
- Development and validation of interpretable machine learning models for postoperative pneumonia prediction.Frontiers in public health · 2024Article
- Artificial intelligence across oncology specialties: current applications and emerging tools.BMJ oncology · 2024Review
- MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer.International journal of molecular sciences · 2023Article
- Radiogenomics: a key component of precision cancer medicine.British journal of cancer · 2023Review
- Predicting cervical lymph node metastasis in OSCC based on computed tomography imaging genomics.Cancer medicine · 2023Article
- Gender Medicine in Clinical Radiology Practice.Journal of personalized medicine · 2023Review
- Artificial intelligence applications in pediatric oncology diagnosis.Exploration of targeted anti-tumor therapy · 2023Review
- The application of radiomics in predicting gene mutations in cancer.European radiology · 2022Review
- Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.International journal of molecular sciences · 2021Review
- Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2021Article
- A roadmap for research in medical physics via academic medical centers: The DIVERT Model.Medical physics · 2021Article
- Radiomic and radiogenomic modeling for radiotherapy: strategies, pitfalls, and challenges.Journal of medical imaging (Bellingham, Wash.) · 2021Review
- Development of MR-based preoperative nomograms predicting DNA copy number subtype in lower grade gliomas with prognostic implication.European radiology · 2021Article
- Radiogenomics in Interventional Oncology.Current oncology reports · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning (ML) models due to the enormous amount of diagnostic data used as input and therapeutic data generated as output. An emerging field in precision radiation oncology that can take advantage of ML approaches is radiogenomics, which is the study of the impact of genomic variations on the sensitivity of normal and tumor tissue to radiation. Currently, patients undergoing radiotherapy are treated using uniform dose constraints specific to the tumor and surrounding normal tissues. This is suboptimal in many ways. First, the dose that can be delivered to the target volume may be insufficient for control but is constrained by the surrounding normal tissue, as dose escalation can lead to significant morbidity and rare. Second, two patients with nearly identical dose distributions can have substantially different acute and late toxicities, resulting in lengthy treatment breaks and suboptimal control, or chronic morbidities leading to poor quality of life. Despite significant advances in radiogenomics, the magnitude of the genetic contribution to radiation response far exceeds our current understanding of individual risk variants. In the field of genomics, ML methods are being used to extract harder-to-detect knowledge, but these methods have yet to fully penetrate radiogenomics. Hence, the goal of this publication is to provide an overview of ML as it applies to radiogenomics. We begin with a brief history of radiogenomics and its relationship to precision medicine. We then introduce ML and compare it to statistical hypothesis testing to reflect on shared lessons and to avoid common pitfalls. Current ML approaches to genome-wide association studies are examined. The application of ML specifically to radiogenomics is next presented. We end with important lessons for the proper integration of ML into radiogenomics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.